Management strategies for diseases are constantly evolving with advances in the medical environment and the accumulation of clinical evidence. In chronic pancreatitis as well, the disease concept and diagnostic criteria for early chronic pancreatitis have been established, enabling medical intervention based on lifestyle guidance. In medical treatment of the disease, nutritional therapy, administration of analgesics, and pancreatic enzyme replacement therapy are primarily implemented according to the presence or absence of pain syndrome or steatorrhea. Regarding endotherapy, in addition to transpapillary pancreatic stone removal and pancreatic duct stenting via ERCP, peroral pancreatoscopy-guided lithotripsy and EUS-guided interventions are being actively performed. However, several key points remain controversial: the optimal timing for transitioning from medical to surgical treatment, the indications for endoscopic and surgical interventions with consideration of pancreatic function preservation, and the utility of screening for pancreatic cancer during follow-up. This symposium aims to review the current state of the evolving management of chronic pancreatitis, share the remaining challenges, and discuss future prospects. We welcome a wide range of abstract submissions.